ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

OPGN OpGen Inc

0.449
-0.086 (-16.07%)
Apr 30 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
OpGen Inc OPGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.086 -16.07% 0.449 18:44:30
Open Price Low Price High Price Close Price Previous Close
0.50 0.4026 0.50 0.403 0.535
more quote information »

Recent News

Date Time Source Heading
4/29/202415:05GLOBEOpGen Provides Update on Business Operations and Strategic..
4/23/202415:15GLOBEOpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
3/26/202415:20APSShares Rip In Reaction To Activist Investor Becoming CEO
3/25/202415:05GLOBEOpGen Announces Acquisition of Preferred Stock by David..
2/13/202415:30EDGAR2Form 8-K - Current report
2/08/202406:30EDGAR2Form 8-K - Current report
1/09/202415:30EDGAR2Form 8-K - Current report
12/12/202315:58EDGAR2Form 8-K - Current report
12/05/202315:37EDGAR2Form 8-K - Current report
11/23/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/14/202315:30GLOBEOpGen Reports Third Quarter 2023 Financial Results and..
11/13/202315:59EDGAR2Form S-3 - Registration statement under Securities Act of..
11/07/202315:30EDGAR2Form 8-K - Current report
10/26/202315:30EDGAR2Form 8-K - Current report
10/16/202315:30EDGAR2Form 8-K - Current report
10/13/202316:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/202316:17EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/13/202316:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/202316:14EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/13/202316:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/12/202311:32GLOBEOpGen Enters Into Warrant Inducement Transaction for up to..
10/11/202315:40EDGAR2Form 8-K - Current report
10/11/202315:30EDGAR2Form 8-K - Current report
9/28/202315:24EDGAR2Form RW - Registration Withdrawal Request
9/08/202315:30EDGAR2Form 8-K - Current report
9/07/202315:30EDGAR2Form 8-K - Current report
8/14/202307:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:31EDGAR2Form 8-K - Current report
8/10/202315:15GLOBEOpGen Reports Second Quarter 2023 Financial Results and..
8/07/202306:30GLOBEOpGen’s Subsidiary Ares Genetics Releases New Features to..
8/03/202307:00GLOBEOpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration..
8/03/202306:30GLOBEOpGen to Provide Business Update and Financial Results for..
8/01/202308:40EDGAR2Form DEF 14A - Other definitive proxy statements
7/21/202315:55EDGAR2Form PRE 14A - Other preliminary proxy statements
7/19/202306:30GLOBEOpGen’s Subsidiary Curetis Meets Milestones of Extended and..
7/14/202315:30EDGAR2Form S-1 - General form for registration of securities under..
7/05/202315:30EDGAR2Form 8-K - Current report
6/30/202315:30EDGAR2Form 8-K - Current report
6/26/202306:30GLOBEOpGen Subsidiary Ares Genetics Successfully Maintains Key..
6/22/202306:30GLOBEOpGen’s Subsidiary Curetis Receives Batch of Ten New..
6/20/202306:30GLOBEOpGen Presents Unyvero Urinary Tract Infection Panel Trial..
5/15/202315:15GLOBEOpGen Reports First Quarter 2023 Financial Results and..
5/08/202306:30GLOBEOpGen to Provide Business Update and Financial Results for..
5/04/202315:30GLOBEOpGen Announces Closing of $3.5 Million Public Offering
5/01/202320:00GLOBEOpGen Announces Pricing of $3.5 Million Public Offering

Your Recent History

Delayed Upgrade Clock